Heparin Sodium Injection, Solution
Product Images NDC 51662-1411

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Heparin Sodium (NDC 51662-1411). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hf Acquisition Co Llc, Dba Healthfirst, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Bag Labeling (Bag Label)

This is a description of a drug product containing 250mL of Heparin Sodium in 0.45% Sodium Chloride Injection. The solution has a concentration of 100 use units/mL of Heparin, and each 100mL contains 10,000 USP units of Porcine Heparin. It may contain sodium hydroxide and/or hydrochloric acid for pH adjustment and it is sterile. The product is a single-dose container and should not have any additives made to it. The unused portion should be discarded. The usual dosage information can be found in the insert. This product contains DEHP and is made by Hospira, Inc. in Lake Forest, IL.*

FDA Label Image

Dosage (Dosage)

Table 1: Recommended Adult Full-Dose Heparin Regimens for Therapeutic Anticoagulant Effect. The table outlines two methods of administering heparin, intermittent and continuous, along with recommended doses for each. The recommended dose for intermittent administration is an initial 10,000 units by intravenous injection, followed by 5,000-10,000 units every 4 to 6 hours. For continuous administration, the recommended initial dose is 5,000 units via intravenous injection, followed by 20,000-40,000 units over a 24-hour period. The table note indicates that the recommended doses are based on a 150 lb. patient.*

FDA Label Image

Highlights 1 (Highlights 1)

This is a dosing guide for administration of heparin via intravenous injection. For intermittent injection, the initial dose is 10,000 units followed by 5,000 to 10,000 units every 4 to 6 hours. For continuous infusion, the initial dose is 5,000 units followed by a range of 20,000 to 40,000 units over a 24 hour period. The guide is based on a patient weight of 150 pounds (68 kilograms).*

FDA Label Image

Highlights 2 (Highlights 2)

This text provides information on the initial dose of an intravascular medication administered via total body perfusion. The recommended starting dose is 2 150 units/kg, and it may need to be adjusted for longer procedures.*

FDA Label Image

Highlights 3 (Highlights 3)

This text provides a brief instruction for using dialysis equipment to administer Intravascular via Extracorporeal therapy. It advises the user to follow the equipment manufacturer's operating directions carefully.*

FDA Label Image

How Supplied (How Supplied)

This text provides information about the unit of sale and NDC codes for multiple medication concentrations. The concentration of each medication is provided in USP units per mL or per 250mL/500mL container. The packaging format is also included, with descriptions of flexible plastic containers for 250mL and 500mL.*

FDA Label Image

Logo (Logo)

FDA Label Image

Serialized Labeling (Serilized Labeling Current)

This is a description of the medication Heparin M Sodium. It is a solution that is intended for intravenous use and contains 10,000 units of heparin sodium per 100 mL, along with 0.45% Sodium Chloride Injection. It is used to prevent blood clots and may contain sodium hydroxide and/or hydrochloric acid for pH adjustment. It is a sterile, single-use container that should be discarded after use. The usual dosage is detailed in an insert, and no additives should be made to the solution. The manufacturer is Rospira, Inc.*

FDA Label Image

Structure (Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.